Dr Feagan gave an oral paper presentation on the findings of the U-ACHIEVE maintenance trial evaluating the benefits of high-dose upadacitinib in the treatment of active ulcerative colitis, at the 2022 ACG Annual Scientific Meeting on October...
Dr Feagan gave an oral paper presentation on the findings of the U-ACHIEVE maintenance trial evaluating the benefits of high-dose upadacitinib in the treatment of active ulcerative colitis, at the 2022 ACG Annual Scientific Meeting on October...
Dr Feagan gave an oral paper...